Protalix BioTherapeutics' (PLX) Alfataliglicerase Approved in Brazil for the Treatment of Certain Gaucher Disease
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (NYSE: PLX) announced that the Brazilian National Health Surveillance Agency (ANVISA, Agencia Nacional de Vigilancia Sanitaria) has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
